Norgine

À propos

Norgine is a leading European specialist pharmaceutical company with 110 years’ heritage. Norgine acquires, develops and commercialises specialist and transformative products through its infrastructure that add value to healthcare systems and make a difference to patients. We are a partner for a healthy life. Norgine has a presence in all major European markets and in Australia and employs over 1,000 people. Norgine operates a well-established European and Australian infrastructure - with 160 staff in development, 470 in commercial, 380 in manufacturing and supply with the remainder employed in global shared services, general and administrative functions. Norgine specialises in gastroenterology, hepatology , cancer and supportive care therapy areas and also manages a portfolio of well established brands. For its employees, Norgine provides a dynamic culture in which they can feel energised and rewarded for their contribution. Norgine's core values of One Norgine, Innovation and Trustworthiness underpin all of our activities. They are fundamental to achieving our vision to be the 'go to'? European specialist pharma company. Norgine is headquartered in the Netherlands with global operations in Amsterdam and in Harefield, UK. Norgine owns a R&D site in Hengoed, Wales and two manufacturing sites in Hengoed, Wales and Dreux, France. In 2012, Norgine established a complementary business Norgine Ventures, supporting innovative healthcare companies through the provision of debt-like financing in Europe and the US. For more information, please visit www.norgineventures.com.